CN103705711A - Chinese herbal compound for treating diabetes and preparation method thereof - Google Patents

Chinese herbal compound for treating diabetes and preparation method thereof Download PDF

Info

Publication number
CN103705711A
CN103705711A CN201410002188.3A CN201410002188A CN103705711A CN 103705711 A CN103705711 A CN 103705711A CN 201410002188 A CN201410002188 A CN 201410002188A CN 103705711 A CN103705711 A CN 103705711A
Authority
CN
China
Prior art keywords
chinese medicine
medicine composition
chinese herbal
extract
distilled water
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
CN201410002188.3A
Other languages
Chinese (zh)
Other versions
CN103705711B (en
Inventor
王学美
黎巍威
王琳琳
富宏
宋芳娇
宋宜祥
杨金霞
曾克武
屠鹏飞
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Peking University First Hospital
Original Assignee
Peking University First Hospital
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Peking University First Hospital filed Critical Peking University First Hospital
Priority to CN201410002188.3A priority Critical patent/CN103705711B/en
Publication of CN103705711A publication Critical patent/CN103705711A/en
Application granted granted Critical
Publication of CN103705711B publication Critical patent/CN103705711B/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Images

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a Chinese herbal compound for treating diabetes and a preparation method thereof. The Chinese herbal compound is prepared from humifuse euphorbia herb, the root of red-rooted salvia, astragali radix, rhizoma anemarrhenae and coptis chinensis. In the Chinese herbal compound, the humifuse euphorbia herb has the main functions of clearing away heat and toxic materials, invigorating the circulation of blood and cooling blood and serves as monarch; the root of red-rooted salvia has the functions of promoting blood circulation to remove blood stasis and clearing away the heart fire to relieve restlessness; the coptis chinensis has the combined functions of clearing away heat and drying dampness as well as purging fire to remove toxin; the root of red-rooted salvia and the coptis chinensis serve as minister; the astragali radix has the functions of tonifying spleen and benefiting qi; the rhizoma anemarrhenae has the integrated functions of clearing heat and nourishing yin. The astragali radix and the rhizoma anemarrhenae serve as assistant and guide. The Chinese herbal compound has an obvious hypoglycemic effect.

Description

A kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof
Technical field
The present invention relates to a kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof.
Background technology
Diabetes spp is in motherland's medical science category of " quenching one's thirst ", ancient Chinese medicine doctor explicitly point out quench one's thirst for sick, no matter which kind of reason, no matter in what sick position, all by showing tremendous enthusiasm interior Sheng, looking angry pent-up is stagnant, consumption impairment of YIN Tianjin causes due to body fluid loss.Think that " pyretic toxicity " is the basic paathogenic factor of diabetes and the important pathogenesis.
Conventional hypoglycemic pcm is just like KELENING granule, YUQUAN WAN (Yuquan capsule), JIANGTANGSHU JIAONANG, SHENSHI JIANGTANG JIAONANG, blood sugar lowering first sheet etc. in the market, and these drug mains will, based on the scorching pathogenic pathogenesis of the deficiency of YIN, be take supplementing QI and nourishing YIN method for the treatment of as main.
Summary of the invention
The object of this invention is to provide a kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof.
A kind of Chinese medicine composition for the treatment of diabetes provided by the invention, by Herba Euphorbiae Humifusae, Radix Salviae Miltiorrhizae, Radix Astragali, the Rhizoma Anemarrhenae and Rhizoma Coptidis form.
In above-mentioned Chinese medicine composition, described Herba Euphorbiae Humifusae, Radix Salviae Miltiorrhizae, Radix Astragali, the mass ratio of the Rhizoma Anemarrhenae and Rhizoma Coptidis is 1.32-5.34:1.76-7.12:0.88-6:0.88-3.56:1.
The method of preparing the Chinese medicine extract for the treatment of diabetes also belongs to a protection scope of the present invention, comprises the steps:
Described Chinese medicine composition is decocted in distilled water, obtain decoction liquor, decoction liquor is filtered and carried out concentrate drying again, obtain extract.
In said method, the mode of described decoction, for being first heated to boiling, continuing little fire and decocts after boiling.
In above-mentioned arbitrary described method, before described decoction, also comprise the step that described Chinese medicine composition is soaked in described distilled water.
In above-mentioned arbitrary described method, the time of described immersion is 2h;
The time that described little fire decocts is 1h.
In above-mentioned arbitrary described method, the volume ratio of described Chinese medicine composition and described distilled water is 1: 7.
The Chinese medicine extract that above-mentioned arbitrary described method obtains also belongs to protection scope of the present invention.
Traditional Chinese medicine liquid also belongs to a protection scope of the present invention, by above-mentioned Chinese medicine extract, is dissolved in distilled water and is made.
The application that above-mentioned Chinese medicine composition, above-mentioned Chinese medicine extract and/or above-mentioned traditional Chinese medicine liquid prevent and/or treat in the product of diabetes in preparation also belongs to protection scope of the present invention;
And/or,
The application in the product of preparation reduction blood sugar concentration of above-mentioned Chinese medicine composition, above-mentioned Chinese medicine extract and/or above-mentioned traditional Chinese medicine liquid also belongs to protection scope of the present invention.
In Chinese medicine compound provided by the invention, Herba Euphorbiae Humifusae heat-clearing and toxic substances removing, promoting blood circulation and cooling blood is monarch; Radix Salviae Miltiorrhizae blood circulation promoting and blood stasis dispelling, the relieving restlessness that clears away heart-fire, Rhizoma Coptidis heat clearing and damp drying, eliminating fire and detoxication is minister altogether; Radix Astragali invigorating the spleen and replenishing QI, Rhizoma Anemarrhenae clearing away heat and nourishing YIN is altogether for assistant makes.The present invention sets forth one's views so that the traditional Chinese medical science " pyretic toxicity " is theoretical, and treatment diabetes be take heat-clearing and toxic substances removing as main, are equipped with blood circulation promoting and blood stasis dispelling, and blood sugar lowering is evident in efficacy.
Accompanying drawing explanation
Fig. 1 is OGTT testing result before administration.
Fig. 2 is OGTT testing result after administration.
The specific embodiment
The experimental technique using in following embodiment if no special instructions, is conventional method.
In following embodiment, material used, reagent etc., if no special instructions, all can obtain from commercial channels.
Metformin hydrochloride (crude drug) is purchased from China Resources Double-Crane Pharmaceutical Co., Ltd., and lot number is A-11411212002.
Herba Euphorbiae Humifusae, Radix Salviae Miltiorrhizae, Radix Astragali, the Rhizoma Anemarrhenae and Rhizoma Coptidis are all purchased from Chinese medicine pharmacy of Peking University First Hospital.
Healthy male C 57 BL/6 J mouse, 25-30g, 9 week age, purchased from Beijing Vital River Experimental Animals Technology Co., Ltd..
Healthy male kk/Upj-Ay mice, 30-40g, 9 week age, purchased from China biotech inc, Fukang, Beijing.
Chinese medicine compound and the preparation thereof of embodiment 1, treatment diabetes
One, the preparation of Chinese medicine compound 1 extract: get Herba Euphorbiae Humifusae 158.4g, Radix Salviae Miltiorrhizae 211.2g, Radix Astragali 105.6g, Rhizoma Anemarrhenae 105.6g, it is 1.32:1.76:0.88:0.88:1 that Rhizoma Coptidis 120g amounts to ratio between each medicine of 700.8g(), to start decoction after 7 times of volume distilled water immersion 2h, be heated to boiling, after boiling, continue little fire and decoct 1h, filter, collect medicinal liquid, decoct altogether twice.The medicinal liquid that merges twice reduces pressure after cryoconcentration, through lyophilization, collects lyophilized powder 260.71g altogether after 2 days, and extraction ratio is 0.372.
Two, the preparation of Chinese medicine compound 2 extracts: get Herba Euphorbiae Humifusae 360g, Radix Salviae Miltiorrhizae 480g, Radix Astragali 240g, Rhizoma Anemarrhenae 240g, it is 3:4:2:2:1 that Rhizoma Coptidis 120g amounts to ratio between each medicine of 1440g() to start decoction after 7 times of volume distilled water immersion 2h, be heated to boiling, after boiling, continue little fire and decoct 1h, filter, collect medicinal liquid, decoct altogether twice.The medicinal liquid that merges twice reduces pressure after cryoconcentration, through lyophilization, collects lyophilized powder 551.93g altogether after 3 days, and extraction ratio is 0.383.
Three, the preparation of Chinese medicine compound 3 extracts: get Herba Euphorbiae Humifusae 640.8g, Radix Salviae Miltiorrhizae 854.4g, Radix Astragali 720g, Rhizoma Anemarrhenae 427.2g, it is 5.34:7.12:6:3.56:1 that Rhizoma Coptidis 120g amounts to ratio between each medicine of 2762.4g(), to start decoction after 7 times of volume distilled water immersion 2h, be heated to boiling, after boiling, continue little fire and decoct 1h, filter, collect medicinal liquid, decoct altogether twice.The medicinal liquid that merges twice reduces pressure after cryoconcentration, through lyophilization, collects lyophilized powder 1038.66g altogether after 5 days, and extraction ratio is 0.376.
The hypoglycemic activity of the Chinese medicine compound of embodiment 2, treatment diabetes
One, animal grouping
Be divided into following 6 groups:
Blank group: healthy male C 57 BL/6 J mouse, 25-30g, 9 week age, totally 8.
Diabetic groups: healthy male kk/Upj-Ay mice, 30-40g, 9 week age, totally 60.The male kk/Upj-Ay mice of health adaptability is raised 1 week, survey random blood sugar >11.1mmolL -1or fasting glucose >7.0mmolL -1be considered as diabetes model, select altogether 45, and it is divided into model control group, metformin hydrochloride group (200mg/kg), Chinese medicine compound 1 experimental group, Chinese medicine compound 2 experimental grouies, Chinese medicine compound 3 experimental grouies, 9 every group at random.
Two, respectively organize the dosage of mice
During blank group mouse stomach, give distilled water, according to 0.1ml10g -1carry out gavage, every day, gavage was 1 time, and gavage is 2 weeks continuously.
During model control group gavage, give distilled water, according to 0.1ml10g -1carry out gavage, every day, gavage was 1 time, and gavage is 2 weeks continuously.
The administration of metformin hydrochloride group is metformin hydrochloride, according to 200mg/kg, carries out gavage, during gavage, metformin hydrochloride is dissolved with distilled water, is mixed with 20mg/ml concentration, and every day, gavage was 1 time, and gavage is 2 weeks continuously.
Chinese medicine compound 1 experimental group administration is the extract of the Chinese medicine compound 1 of embodiment 1, according to 8g/kg, carries out gavage, during gavage, the extract of Chinese medicine compound 1 is dissolved with distilled water, is mixed with 0.8g/ml concentration, and every day, gavage was 1 time, and gavage is 2 weeks continuously.
Chinese medicine compound 2 experimental grouies are the extract of the Chinese medicine compound 2 of embodiment 1 preparation, according to 8g/kg, carry out gavage, during gavage, the extract of Chinese medicine compound 2 are dissolved with distilled water, are mixed with 0.8g/ml concentration, and every day, gavage was 1 time, and gavage is 2 weeks continuously.
Chinese medicine compound 3 experimental grouies are the extract of the Chinese medicine compound 3 of embodiment 1 preparation, according to 8g/kg, carry out gavage, during gavage, the extract of Chinese medicine compound 3 are dissolved with distilled water, are mixed with 0.8g/ml concentration, and every day, gavage was 1 time, and gavage is 2 weeks continuously.
Three, the detection of blood glucose before administration and after administration
(1) detection of index before administration
1, take the body weight of respectively organizing mice.
2, each group mice fasting be can't help to water 4h, get tail point venous blood and adopt glucose oxidase method to detect fasting glucose.
3, oral glucose tolerance (OGTT) detects
After having surveyed fasting glucose, by the dosage of 2g/kg, give immediately respectively to organize mouse stomach glucose solution, and after administration 30,60,120min collects Mouse Tail-tip venous blood, adopts glucose oxidase method to detect each time point blood glucose, calculates blood sugar concentration area under curve (AUCg).
Testing result is as shown in table 1.
Before table 1 administration, respectively organize Mouse Weight, fasting glucose and OGTT area under curve
Figure BDA0000452739770000041
Figure BDA0000452739770000042
As shown in Figure 1, in Fig. 1,1 group of ratio represents Chinese medicine compound 1 experimental group to OGTT testing result before administration, and 2 groups of ratios represent Chinese medicine compound 2 experimental grouies, and 3 groups of ratios represent Chinese medicine compound 3 experimental grouies.
(2) detection of index after administration
1, after gavage, take the body weight of respectively organizing mice the last time.
2, respectively organize mice the last time after gavage, water 4h is can't help in fasting, surveys fasting glucose, surveys 2h gastric infusion before fasting glucose.
3, oral glucose tolerance (OGTT) detects
After having surveyed fasting glucose, by the dosage of 2g/kg, give immediately respectively to organize mouse stomach glucose solution, and after administration 30,60,120min collects Mouse Tail-tip venous blood, adopts glucose oxidase method to detect each time point blood glucose,
Testing result is as shown in table 2.
Table 2 Chinese medicine compound is organized the impact of Mouse Weight, fasting glucose and OGTT area under curve to each
Figure BDA0000452739770000043
Figure BDA0000452739770000044
Note: 1. body weight: with model control group comparison, * * * P<0.001.
2. fasting glucose and OGTT area under curve (AUCg): with model control group comparison, * P<0.05, * * P<0.01, * * * P<0.001.
After administration, as shown in Figure 2, in Fig. 2,1 group of ratio represents Chinese medicine compound 1 experimental group to OGTT testing result, and 2 groups of ratios represent Chinese medicine compound 2 experimental grouies, and 3 groups of ratios represent Chinese medicine compound 3 experimental grouies.
Table 2 shows, after two weeks, Chinese medicine compound of the present invention all has the effect that reduces diabetic mice fasting glucose and reduce OGTT area under curve.

Claims (10)

1. treat a Chinese medicine composition for diabetes, by Herba Euphorbiae Humifusae, Radix Salviae Miltiorrhizae, Radix Astragali, the Rhizoma Anemarrhenae and Rhizoma Coptidis form.
2. Chinese medicine composition according to claim 1, is characterized in that: described Herba Euphorbiae Humifusae, Radix Salviae Miltiorrhizae, Radix Astragali, and the mass ratio of the Rhizoma Anemarrhenae and Rhizoma Coptidis is 1.32-5.34:1.76-7.12:0.88-6:0.88-3.56:1;
Described Herba Euphorbiae Humifusae, Radix Salviae Miltiorrhizae, Radix Astragali, the mass ratio of the Rhizoma Anemarrhenae and Rhizoma Coptidis is specially the ratio shown in (1)-(3) are arbitrary as follows:
(1)1.32:1.76:0.88:0.88:1;
(2)3:4:2:2:1;
(3)5.34:7.12:6:3.56:1。
3. a method of preparing the Chinese medicine extract for the treatment of diabetes, comprises the steps:
Chinese medicine composition described in claim 1 or 2 is decocted in distilled water, obtain decoction liquor, decoction liquor is filtered and carried out concentrate drying again, obtain extract.
4. method according to claim 3, is characterized in that: the mode of described decoction, for being first heated to boiling, continuing little fire and decocts after boiling.
5. according to the method described in claim 3 or 4, it is characterized in that: before described decoction, also comprise the step that described Chinese medicine composition is soaked in described distilled water.
6. according to the arbitrary described method of claim 3-5, it is characterized in that: the time of described immersion is 2h;
The time that described little fire decocts is 1h.
7. according to the arbitrary described method of claim 3-6, it is characterized in that: the volume ratio of described Chinese medicine composition and described distilled water is 1: 7.
8. the Chinese medicine extract being obtained by the arbitrary described method of claim 3-7.
9. a traditional Chinese medicine liquid, is dissolved in distilled water and is made by Chinese medicine extract claimed in claim 8.
10. the Chinese medicine composition described in claim 1 or 2, Chinese medicine extract claimed in claim 8 and/or traditional Chinese medicine liquid claimed in claim 9 prevent and/or treat the application in the product of diabetes in preparation;
And/or,
The application in the product of preparation reduction blood sugar concentration of Chinese medicine composition described in claim 1 or 2, Chinese medicine extract claimed in claim 8 and/or traditional Chinese medicine liquid claimed in claim 9.
CN201410002188.3A 2014-01-03 2014-01-03 A kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof Active CN103705711B (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201410002188.3A CN103705711B (en) 2014-01-03 2014-01-03 A kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201410002188.3A CN103705711B (en) 2014-01-03 2014-01-03 A kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof

Publications (2)

Publication Number Publication Date
CN103705711A true CN103705711A (en) 2014-04-09
CN103705711B CN103705711B (en) 2016-02-10

Family

ID=50399297

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201410002188.3A Active CN103705711B (en) 2014-01-03 2014-01-03 A kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof

Country Status (1)

Country Link
CN (1) CN103705711B (en)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105943819A (en) * 2016-06-22 2016-09-21 北京大学第医院 Traditional Chinese medicine alcohol extract for treating diabetic nephropathy and preparation method and application thereof
CN105943818A (en) * 2016-06-22 2016-09-21 北京大学第医院 Chinese traditional medicine water extract for treating diabetic nephropathy as well as preparation method and application thereof
CN108452115A (en) * 2017-02-21 2018-08-28 成惠娜 A kind of health instant powder that diabetes patient takes

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
韩天雄等: "颜乾麟教授辨治糖尿病临证思维特点探析", 《浙江中医药大学学报》, vol. 36, no. 5, 31 May 2012 (2012-05-31) *

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105943819A (en) * 2016-06-22 2016-09-21 北京大学第医院 Traditional Chinese medicine alcohol extract for treating diabetic nephropathy and preparation method and application thereof
CN105943818A (en) * 2016-06-22 2016-09-21 北京大学第医院 Chinese traditional medicine water extract for treating diabetic nephropathy as well as preparation method and application thereof
CN108452115A (en) * 2017-02-21 2018-08-28 成惠娜 A kind of health instant powder that diabetes patient takes

Also Published As

Publication number Publication date
CN103705711B (en) 2016-02-10

Similar Documents

Publication Publication Date Title
CN103099959B (en) Traditional Chinese medicine preparation for treating ulcerative colitis and preparation method thereof
CN102058767B (en) Chinese medicine for treating senile chronic bronchitis and method for preparing pills thereof
CN103961558A (en) Dendrobium candidum instant granule for alleviating hangover and protecting liver
CN101124932A (en) Decoction preparation for treating viral hepatitis associated with fatty liver diseases
CN103705711B (en) A kind of Chinese medicine compound for the treatment of diabetes and preparation method thereof
CN104043050A (en) Traditional Chinese medicine composition for treating cholecystitis
CN100571740C (en) The Chinese medicine composition of a kind of blood sugar lowering, blood fat reducing and method for making and application
CN104083680B (en) Traditional Chinese medicinal composition, extract and preparation for promoting rehabilitation of liver diseases
CN103272176B (en) Traditional Chinese medicine composition for treating cardiovascular disease and preparation method thereof
CN104435567A (en) Traditional Chinese medicinal composition containing gynostemma pentaphyllum for treating gout
CN108522764A (en) A kind of health-care cold tea and preparation method thereof
CN102895445A (en) Traditional Chinese medicine for treating dysentery
CN106581236A (en) Medicinal composition for promoting gastric motility, and preparation method and application thereof
CN102293883B (en) Chinese medicinal composition for treating child acute upper respiratory tract infection, and preparation method and application thereof
CN102631479B (en) Traditional Chinese medicine composition for improving damp heat constitution, preparation and preparation method thereof
CN102940839A (en) Traditional Chinese medicine composition for treating chronic atrophic gastritis
CN105169327B (en) A kind of pharmaceutical composition and preparation method thereof for treating porcine diarrhea disease
CN105288300A (en) Traditional Chinese medicine composition for treating migraine without aura
CN106668616A (en) Compound Dendrobium officinale Kimura et Migo oral solution with stomach-nourishing function
CN104547923B (en) A kind of Chinese medicine composition for treating gouty nephropathy and its application
CN110368469A (en) Join glue stilbene particle drink
CN104606471A (en) Traditional Chinese medicine composition for treating chronic gastritis
CN104436022A (en) Hemsleya-macrosperma-containing traditional Chinese medicine composition for treating diabetes mellitus
CN104127826A (en) Traditional Chinese medicine composition for treating chronic alcoholic liver disease
CN104337898B (en) A kind of Chinese medicine composition of the treatment gout containing Semen Pruni

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant